99
Views
29
CrossRef citations to date
0
Altmetric
Drug Evaluation

Thalidomide: a new anticancer drug?

, , , , , , & show all
Pages 1211-1225 | Published online: 02 Mar 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Andreja Kovač, Rosalind A. Wilson, Gurdyal S. Besra, Metka Filipič, Danijel Kikelj & Stanislav Gobec. (2006) New lipophilic phthalimido- and 3-phenoxybenzyl sulfonates: Inhibition of antigen 85C mycolyltransferase activity and cytotoxicity. Journal of Enzyme Inhibition and Medicinal Chemistry 21:4, pages 391-397.
Read now
Philip E Shaheen & Ronald M Bukowski. (2005) Emerging drugs for renal cell carcinoma. Expert Opinion on Emerging Drugs 10:4, pages 773-795.
Read now
Mathias Kees, Markus Raderer, Sylvia Metz-Schimmerl, Andreas Chott & Heinz Gisslinger. (2005) Very good partial response in a patient with MALT-lymphoma of the lung after treatment with low-dose thalidomide. Leukemia & Lymphoma 46:9, pages 1379-1382.
Read now
Verena Jendrossek, Claus Belka & Michael Bamberg. (2003) Novel chemotherapeutic agents for the treatment of glioblastoma multiforme. Expert Opinion on Investigational Drugs 12:12, pages 1899-1924.
Read now

Articles from other publishers (25)

Sandra Domingo, Cristina Solé, Teresa Moliné, Berta Ferrer, Josep Ordi-Ros & Josefina Cortés-Hernández. (2020) Efficacy of Thalidomide in Discoid Lupus Erythematosus: Insights into the Molecular Mechanisms. Dermatology 236:5, pages 467-476.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 795 811 .
A. Ferrazzi, R. Zambello, I. Russo & M. Alaibac. (2014) Psoriasis induced by thalidomide in a patient with multiple myeloma. Case Reports 2014:jun27 1, pages bcr2014204469-bcr2014204469.
Crossref
Wen-wen Lv, Si-ning Qin, Cong-qin Chen, Jin-jie Zhang, Tian-shu Ren, Yong-nan Xu & Qing-chun Zhao. (2014) Isoindolone derivative QSN-10c induces leukemic cell apoptosis and suppresses angiogenesis via PI3K/AKT signaling pathway inhibition. Acta Pharmacologica Sinica 35:5, pages 625-635.
Crossref
D. Nathan Kim, Taek-Keun Nam, Kevin S. Choe & Hak Choy. (2012) Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer. Cancer Research and Treatment 44:2, pages 74-84.
Crossref
Joanne Reid, Moyra Mills, Marie M Cantwell, Chris R Cardwell, Liam J Murray & Michael Donnelly. (2012) Thalidomide for managing cancer cachexia. Cochrane Database of Systematic Reviews 2021:5.
Crossref
Joanne Reid, Michael Donnelly, Marie Cantwell, Chris R Cardwell, Moyra Mills & Liam J Murray. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
. 2010. Meyler's Side Effects of Drugs in Cancer and Immunology. Meyler's Side Effects of Drugs in Cancer and Immunology 491 598 .
Shigeru Suzuki, Takeshi Yamamoto, Etsuko Tokunaga, Shuichi Nakamura, Motohiro Tanaka, Takuma Sasaki & Norio Shibata. (2009) Design and Synthesis of Thalidomide–Deoxyribonucleoside Chimeras. Chemistry Letters 38:11, pages 1046-1047.
Crossref
Iyad N Daher & Edward TH Yeh. (2008) Vascular complications of selected cancer therapies. Nature Clinical Practice Cardiovascular Medicine 5:12, pages 797-805.
Crossref
Wen-Jen Hwu, Ana E. Ayala & Ingrid M. Hernandez. (2008) Alternative temozolomide dosing regimens and novel combinations for the treatment of advanced metastatic melanoma. Oncology Reviews 2:3, pages 183-193.
Crossref
Lukas RadbruchFlorian Strasser, Frank Elsner, Jose Ferraz Gonçalves, Jon Løge, Stein Kaasa, Friedemann Nauck & Patrick Stone. (2008) Fatigue in palliative care patients — an EAPC approach. Palliative Medicine 22:1, pages 13-32.
Crossref
Christopher D. Turner, Susan Chi, Karen J. Marcus, Tobey MacDonald, Roger J. Packer, Tina Young Poussaint, Sridhar Vajapeyam, Nicole Ullrich, Liliana C. Goumnerova, R. Michael Scott, Caitlin Briody, Christine Chordas, Mary Ann Zimmerman & Mark W. Kieran. (2006) Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. Journal of Neuro-Oncology 82:1, pages 95-101.
Crossref
Carlos Camps, Vega Iranzo, Roy M. Bremnes & Rafael Sirera. (2006) Anorexia–Cachexia syndrome in cancer: implications of the ubiquitin–proteasome pathway. Supportive Care in Cancer 14:12, pages 1173-1183.
Crossref
Christian Zimmermann, Heike Gutmann & Juergen Drewe. (2005) Thalidomide does not interact with P-glycoprotein. Cancer Chemotherapy and Pharmacology 57:5, pages 599-606.
Crossref
Jan Komorowski, Hanna Jerczyńska, Agnieszka Siejka, Patrycja Barańska, Hanna Ławnicka, Zofia Pawłowska & Henryk Stępień. (2006) Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA.hy 926 cells. Life Sciences 78:22, pages 2558-2563.
Crossref
Edward T.H. Yeh. (2006) Cardiotoxicity Induced by Chemotherapy and Antibody Therapy. Annual Review of Medicine 57:1, pages 485-498.
Crossref
J. Ockenga & L. Valentini. (2006) Thalidomide: an effective anabolic agent in gastrointestinal cancer cachexia: authors' reply. Alimentary Pharmacology and Therapeutics 23:3, pages 446-447.
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 3343 3360 .
Max Dahele & Kenneth C. H. Fearon. 2006. Cachexia and Wasting: A Modern Approach. Cachexia and Wasting: A Modern Approach 603 617 .
Deepjot Singh & Paula Silverman. 2006. Oncology. Oncology 1747 1759 .
Wen‐Jen Hwu, Eric Lis, Jennifer H. Menell, Katherine S. Panageas, Lynne A. Lamb, Janene Merrell, Linda J. Williams, Susan E. Krown, Paul B. Chapman, Philip O. Livingston, Jedd D. Wolchok & Alan N. Houghton. (2005) Temozolomide plus thalidomide in patients with brain metastases from melanoma. Cancer 103:12, pages 2590-2597.
Crossref
Roy S. Herbst, Pat LoRusso, Takeshi Isobe & Herbert I. Hurwitz. 2005. 225 245 .
Chuanhua Wang, Georgia B Schuller Levis, Eun Bang Lee, William R Levis, Da Wei Lee, Bo Sook Kim, Seung Yong Park & Eunkyue Park. (2004) Platycodin D and D3 isolated from the root of Platycodon grandiflorum modulate the production of nitric oxide and secretion of TNF-α in activated RAW 264.7 cells. International Immunopharmacology 4:8, pages 1039-1049.
Crossref
J. Blake Bartlett, Keith Dredge & Angus G. Dalgleish. (2004) The evolution of thalidomide and its IMiD derivatives as anticancer agents. Nature Reviews Cancer 4:4, pages 314-322.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.